Guilherme Fleury Perini

2.1k total citations
47 papers, 462 citations indexed

About

Guilherme Fleury Perini is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Guilherme Fleury Perini has authored 47 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 13 papers in Genetics. Recurrent topics in Guilherme Fleury Perini's work include Lymphoma Diagnosis and Treatment (23 papers), CNS Lymphoma Diagnosis and Treatment (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Guilherme Fleury Perini is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), CNS Lymphoma Diagnosis and Treatment (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Guilherme Fleury Perini collaborates with scholars based in Brazil, United States and Italy. Guilherme Fleury Perini's co-authors include Nelson Hamerschlak, Jorge Vaz Pinto Neto, Barbara Pro, Fábio Pires de Souza Santos, Lucila Nassif Kerbauy, Pier Luigi Zinzani, Laura Maria Fogliatto, Paulo Vidal Campregher, Jennifer Ma and Fábio Ynoe de Moraes and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Guilherme Fleury Perini

41 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guilherme Fleury Perini Brazil 12 163 156 138 124 75 47 462
Rumiko Okamoto Japan 10 244 1.5× 239 1.5× 105 0.8× 138 1.1× 30 0.4× 27 488
Yaozhong Zhao China 10 149 0.9× 110 0.7× 184 1.3× 65 0.5× 22 0.3× 47 410
Joseph Catlett United States 11 170 1.0× 136 0.9× 151 1.1× 59 0.5× 80 1.1× 15 501
Iris Isufi United States 12 283 1.7× 159 1.0× 96 0.7× 121 1.0× 21 0.3× 61 535
Christine McIntyre Switzerland 14 303 1.9× 202 1.3× 107 0.8× 201 1.6× 42 0.6× 31 634
Stefania Crisci Italy 11 88 0.5× 59 0.4× 139 1.0× 50 0.4× 22 0.3× 27 322
Isabelle Genvresse Germany 12 157 1.0× 104 0.7× 107 0.8× 99 0.8× 22 0.3× 27 472
Idanna Innocenti Italy 14 131 0.8× 227 1.5× 173 1.3× 336 2.7× 16 0.2× 75 638
Hyewon Lee South Korea 12 150 0.9× 62 0.4× 127 0.9× 88 0.7× 19 0.3× 38 424

Countries citing papers authored by Guilherme Fleury Perini

Since Specialization
Citations

This map shows the geographic impact of Guilherme Fleury Perini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guilherme Fleury Perini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guilherme Fleury Perini more than expected).

Fields of papers citing papers by Guilherme Fleury Perini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guilherme Fleury Perini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guilherme Fleury Perini. The network helps show where Guilherme Fleury Perini may publish in the future.

Co-authorship network of co-authors of Guilherme Fleury Perini

This figure shows the co-authorship network connecting the top 25 collaborators of Guilherme Fleury Perini. A scholar is included among the top collaborators of Guilherme Fleury Perini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guilherme Fleury Perini. Guilherme Fleury Perini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Beltrán, Brady, María Torres, Luís Villela, et al.. (2024). Epidemiology of Lymphomas in Latin America. JCO Global Oncology. 10(Supplement_1). 64–65. 1 indexed citations
3.
Zinzani, Pier Luigi, Catherine Thiéblemont, В Я Мельниченко, et al.. (2023). Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: Final Analysis of KEYNOTE-170. Blood. 142(2). 141–145. 31 indexed citations
4.
Zinzani, Pier Luigi, Catherine Thiéblemont, В Я Мельниченко, et al.. (2021). Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL). Blood. 138(Supplement 1). 306–306. 5 indexed citations
5.
Zinzani, Pier Luigi, Radhakrishnan Ramchandren, Armando Santoro, et al.. (2021). Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma. Blood Advances. 6(2). 590–599. 13 indexed citations
6.
Perini, Guilherme Fleury, et al.. (2021). PET-CT Quantitative Parameter Delta Suvmax As a Predictor of Early Relapse in Patients with Difuse Large B-Cell Lymphoma. Blood. 138(Supplement 1). 4580–4580. 1 indexed citations
7.
Perini, Guilherme Fleury, et al.. (2020). Progressive multifocal leukoencephalopathy in a patient with relapsed chronic lymphocytic leukemia treated with Ibrutinib. Hematology Transfusion and Cell Therapy. 44(3). 437–439.
8.
Kuruvilla, John, Radhakrishnan Ramchandren, Armando Santoro, et al.. (2020). KEYNOTE-204: Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) in relapsed or refractory classic Hodgkin lymphoma (R/R cHL).. Journal of Clinical Oncology. 38(15_suppl). 8005–8005. 23 indexed citations
9.
Santos, Fábio Pires de Souza, Guilherme Fleury Perini, Breno Pannia Espósito, et al.. (2018). Hepatic and cardiac and iron overload detected by T2* magnetic resonance (MRI) in patients with myelodisplastic syndrome: A cross-sectional study. Leukemia Research. 76. 53–57. 17 indexed citations
10.
Buccheri, Valéria, et al.. (2018). Hodgkin’s lymphoma unmet medical needs in Brazil: experts’ perspective. 10(2). 118–125. 1 indexed citations
11.
Perini, Guilherme Fleury, et al.. (2018). BCL-2 as therapeutic target for hematological malignancies. Journal of Hematology & Oncology. 11(1). 65–65. 160 indexed citations
12.
13.
Perini, Guilherme Fleury & Barbara Pro. (2013). Brentuximab Vedotin in CD30+ Lymphomas. PubMed. 3(1). 15–23. 19 indexed citations
14.
Pro, Barbara & Guilherme Fleury Perini. (2012). Brentuximab vedotin in Hodgkin's lymphoma. Expert Opinion on Biological Therapy. 12(10). 1415–1421. 14 indexed citations
15.
Campregher, Paulo Vidal, Fábio Pires de Souza Santos, Guilherme Fleury Perini, & Nelson Hamerschlak. (2012). Molecular biology of Philadelphia-negative myeloproliferative neoplasms. SHILAP Revista de lepidopterología. 34(2). 150–155. 12 indexed citations
16.
Pro, Barbara & Guilherme Fleury Perini. (2010). Central nervous system prophylaxis in peripheral T-cell lymphoma. Blood. 115(26). 5427–5427. 15 indexed citations
17.
Perini, Guilherme Fleury & Barbara Pro. (2010). Hepatosplenic gamma-delta T-cell lymphoma, disseminated intravascular coagulation, and systemic mastocytosis: an unusual presentation for a rare disease.. PubMed. 8(10). 693–4. 2 indexed citations
18.
Perini, Guilherme Fleury, Fábio Pires de Souza Santos, & Nelson Hamerschlak. (2009). Alemtuzumab in the reversal of encephalopathy associated with hypereosinophilic syndrome. British Journal of Haematology. 147(5). 592–592. 3 indexed citations
19.
Perini, Guilherme Fleury, et al.. (2009). Smudge cells in peripheral blood smears did not differentiate chronic lymphocytic leukemia from other B-cell chronic lymphoprolipherative diseases. Revista Brasileira de Hematologia e Hemoterapia. 31(5). 333–336. 5 indexed citations
20.
Perini, Guilherme Fleury, et al.. (2001). Síndrome Pré-Menstrual e Desempenho Escolar. Revista Brasileira Ginecologia e Obstetrícia. 23(7). 459–462. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rumiko Okamoto Breakdown of academic impact, for papers by Yaozhong Zhao Breakdown of academic impact, for papers by Joseph Catlett Breakdown of academic impact, for papers by Iris Isufi Breakdown of academic impact, for papers by Christine McIntyre Breakdown of academic impact, for papers by Stefania Crisci Breakdown of academic impact, for papers by Isabelle Genvresse Breakdown of academic impact, for papers by Idanna Innocenti Breakdown of academic impact, for papers by Hyewon Lee
Rankless by CCL
2026